The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Calibrated Automated Thrombin Generation Measurement in Clotting Plasma
Hemker, H. C., Giesen, P., Al Dieri, R., Regnault, V., de Smedt, E., Wagenvoord, R., Lecompte, T., & Béguin, S. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000071636 · Cited by 1,430
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
World distribution of factor V Leiden
Rees, D. C., Cox, M., & Clegg, J. B. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91803-5 · Cited by 1,156
Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141
Self-citationSafety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971
Self-citationNovina, C. D., & Sharp, P. A. (2004) · Nature · doi:10.1038/430161a · Cited by 724
Tabernero, J., Shapiro, G. I., LoRusso, P. M., Cervantes, A., Schwartz, G. K., Weiss, G. J., Paz-Ares, L., Cho, D. C., Infante, J. R., Alsina, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0429 · Cited by 698
Self-citationFalati, S., Gross, P., Merrill-Skoloff, G., Furie, B. C., & Furie, B. (2002) · Nature Medicine · doi:10.1038/nm782 · Cited by 669
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
Bi, L., Lawler, A. M., Antonarakis, S. E., High, K. A., Gearhart, J. D., & Kazazian, H. H. (1995) · Nature Genetics · doi:10.1038/ng0595-119 · Cited by 593
Fitzgerald, K., Frank-Kamenetsky, M., Shulga-Morskaya, S., Liebow, A., Bettencourt, B. R., Sutherland, J. E., Hutabarat, R. M., Clausen, V. A., Karsten, V., Cehelsky, J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61914-5 · Cited by 577
Self-citationInherited antithrombin deficiency: a review
PATNAIK, M. M., & MOLL, S. (2008) · Haemophilia · doi:10.1111/j.1365-2516.2008.01830.x · Cited by 401
Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B
Béguin, S., Lienhart, A., Al Dieri, R., Trzeciak, C., Bordet, J., Hemker, C., Negrier, C., & Dargaud, Y. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-10-0706 · Cited by 336
Self-citationMonoclonal Antibodies to a Synthetic Fibrin-Like Peptide Bind to Human Fibrin But Not Fibrinogen
Hui, K. Y., Haber, E., & Matsueda, G. R. (1983) · Science · doi:10.1126/science.6648524 · Cited by 253
A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.
Weiler-Guettler, H., Christie, P. D., Beeler, D. L., Healy, A. M., Hancock, W. W., Rayburn, H., Edelberg, J. M., & Rosenberg, R. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2006 · Cited by 246
SANTAGOSTINO, E., MANCUSO, M. E., TRIPODI, A., CHANTARANGKUL, V., CLERICI, M., GARAGIOLA, I., & MANNUCCI, P. M. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03767.x · Cited by 217
Bucciarelli, P., Rosendaal, F. R., Tripodi, A., Mannucci, P. M., De Stefano, V., Palareti, G., Finazzi, G., Baudo, F., & Quintavalla, R. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.1026 · Cited by 164
Thrombin generation and phenotypic correlation in haemophilia A
Beltrán-Miranda, C. P., Khan, A., Jaloma‐Cruz, A. R., & Laffan, M. (2005) · Haemophilia · doi:10.1111/j.1365-2516.2005.01107.x · Cited by 148
van Boven, H. H., Vandenbroucke, J. P., Briët, E., & Rosendaal, F. R. (1999) · Blood · doi:10.1182/blood.v94.8.2590.420k40_2590_2594 · Cited by 140
Halimeh, S., Ettingshausen, C. E., Kurnik, K., et al. (2002) · Springer eBooks · doi:10.1007/978-3-642-59383-3_9 · Cited by 118
Halimeh, S., Kurnik, K., Schobeß, R., et al. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615679 · Cited by 109
Lee, C.-R., Lin, C., Hsiao, G., Ko, W., Chen, Y., Yen, M., & Sheu, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613907 · Cited by 107
A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia
Ivanciu, L., Toso, R., Margaritis, P., Pavani, G., Kim, H., Schlachterman, A., Liu, J., Clerin, V. M., Pittman, D. D., Rose-Miranda, R., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1995 · Cited by 72
Self-citationFactor V Leiden improves in vivo hemostasis in murine hemophilia models
Schlachterman, A., Schüttrumpf, J., LIU, J. H., Freguia, C. F., Toso, R., Poncz, M., Camire, R. M., & Arruda, V. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01639.x · Cited by 68
Self-citationBuyue, Y., Whinna, H. C., & Sheehan, J. P. (2008) · Blood · doi:10.1182/blood-2008-01-136820 · Cited by 63
Landesman, Y., Svrzikapa, N., Cognetta, A. B., Zhang, X., Bettencourt, B. R., Kuchimanchi, S., Dufault, K., Shaikh, S., Gioia, M., Akinc, A., et al. (2010) · Silence · doi:10.1186/1758-907x-1-16 · Cited by 61
Self-citationLanglois, N., & Wells, P. S. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613594 · Cited by 55
Heterozygous antithrombin deficiency improves in vivo haemostasis in factor VIII-deficient mice
Bolliger, D., Szlam, F., Suzuki, N., Matsushita, T., & Tanaka, K. A. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-10-0732 · Cited by 54
Cited by
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
The chemical evolution of oligonucleotide therapies of clinical utility
Khvorova, A., & Watts, J. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3765 · Cited by 1,216
Overcoming cellular barriers for RNA therapeutics
Dowdy, S. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3802 · Cited by 1,139
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics
Springer, A. D., & Dowdy, S. F. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0736 · Cited by 711
Metadata
- Authors
- Sehgal, A., Barros, S., Ivanciu, L., Cooley, B., Qin, J., Racie, T., Hettinger, J., Carioto, M., Jiang, Y., Brodsky, J., Prabhala, H., Zhang, X., Attarwala, H., Hutabarat, R., Foster, D., Milstein, S., Charisse, K., Kuchimanchi, S., Maier, M. A., Nechev, L., Kandasamy, P., Kel'in, A. V., Nair, J. K., Rajeev, K. G., Manoharan, M., Meyers, R., Sorensen, B., Simon, A. R., Dargaud, Y., Negrier, C., Camire, R. M., & Akinc, A.
- Venue
- Nature Medicine
- Published
- 2015-04-13
- Volume
- 21
- Issue
- 5
- Pages
- 492-497
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2027319450
- Cited by
- 306
- References
- 28
- FWCI
- 27.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
